Vitamin D3 accounts for 83% of total revenue: Prashant Nagre, DIL
  • WebDesk BTVI
  • Jun 07 2019

Prashant Nagre, CEO of Fermenta Biotech Limited, a subsidiary of DIL, says the company, which has been producing Vitamin D3 products over the last 60 years, gets about 83% of revenue from Vitamin D3. On the firm’s future Nagre says the growth rate is likely to be 15-20%. He also adds that the firm has plans to expand further in nutritional and wellness space.